Status:
UNKNOWN
More Air - Better Performance - Faster Recovery
Lead Sponsor:
Central Jutland Regional Hospital
Collaborating Sponsors:
Sygekassernes Helsefond
Conditions:
Functional Independence
Respiratory Insufficiency
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to investigate i) the effect of 3 weeks IMT to adults post-stroke to maximal inspiratory pressure (MIP) and ii) the effects of 3 weeks IMT to the degree of dependency in...
Detailed Description
Background: Stroke results in varying disabilities physical, cognitive, emotional and/or social both in short term and long term. Motor impairments are significantly persistent consequences post-strok...
Eligibility Criteria
Inclusion
- First time brain infarction or brain haemorrhage 0-6 month.
- Able to give written consent and being cognitive and communicative able to understand and participate in the maximal inspiration pressure test (MIP)
- Reduced MIP below gender and age specific normal standard
Exclusion
- Diagnosis of myocardial infarction within the last 3 months
- Significant pulmonary disease (severe COPD), saturation below 90 if having COPD for others saturation below 92
- Neurological deficits other than stroke
- Facial palsy that affects proper labial occlusion
- Dizziness or nausea/vomiting during MIP-testing.
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04686019
Start Date
April 15 2021
End Date
September 30 2023
Last Update
August 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Hospital Hammel Neurocenter
Hammel, Denmark, 8450